FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Oschner Fertility Center Cited for HCT/P Violations

[ Price : $8.95]

FDAs New Orleans District Office warns The Fertility Center at Ochsner over deviations from HCT/P regulations.

Aventis Pays $190 Million in Anzemet Pricing Case

[ Price : $8.95]

Sanofi-Aventis settles a whistleblower suit over Anzemet pricing and marketing for more than $190 million.

BD Diagnostics 510(k) for GeneOhm StaphSR Assay

[ Price : $8.95]

BD Diagnostics submits a 510(k) to add additional claims for the BD GeneOhm StaphSR assay for rapid and simultaneous identificatio...

Researchers Suggest Avandia Withdrawal

[ Price : $8.95]

Researchers say health plans and physicians should stop prescribing Avandia because of an increased risk of heart problems; others...

FDA Panel to Review Medtronic Endeavor Stent

[ Price : $8.95]

FDA says it will convene its Circulatory System Devices Panel of the Medical Devices Advisory Committee 10/10 to review a Medtroni...

FDA Safety Alert on Roches Rocephin

[ Price : $8.95]

FDA warns healthcare providers about severe interactions when Roches Rocephin is administered with a calcium-containing intravenou...

Mammography Advisory Committee to Meet

[ Price : $8.95]

Federal Register Notice: FDAs National Mammography Quality Assurance Advisory Committee will meet 11/5.

Learning to Use Social Media

[ Price : $8.95]

TNS Media Intelligence/Cymfony issues a white paper to help drug companies learn to use social media as part of their marketing mi...

Latest FDA Warning Letters

[ Price : $8.95]

In its latest batch of Warning Letters, FDA cites Melanocorp, Ochsner Clinic Foundation and Wheaton Beauty Supply.

FDA Trasylol Safety Analysis Finds Renal Failure Risk

[ Price : $8.95]

An FDA safety evaluation of a Trasylol observational study that was mistakenly not provided last year finds the drug is associated...